I received a Bachelor of Arts (B.A.) degree in Psychology from Wheaton College in Chicago. I obtained my medical degree (M.D.) and a Master of Science degree (M.S.) from the University of Iowa. I went on to complete my psychiatry residency training at UCSD and an additional 2 year addiction fellowship training at the San Diego VA Medical Center and UCSD. I am licensed to practice medicine in the State of California and I am board certified in Psychiatry as well as in Addiction Medicine (ASAM). I am also certified to use suboxone and/or subutex for opioid detoxification and chronic maintenance.

My professional interests focus on the pharmacological treatment and psychosocial rehabilitation for dual diagnosis (concurrent drug/alcohol & psychiatric disorders). I have extensive experiences in treating and teaching areas relating to chemical dependency, addictive disorders, psychopharmacology, and psychosocial treatment. I have published more than 60 articles and have greater than 100 academic presentations. I am on the editorial boards of several journals. I have received numerous teaching and patient care awards. Most recently I was awarded the United States NAMI National’s Exemplary Psychiatrist Award, as well as the NAMI’s Peggy and Don Richardson Memorial Award.



John W. Tsuang, M.D., M.S.

Clinical Professor(Compensated), Step IV, UCLA School of Medicine, Department of Psychiatry, Los Angeles, CA

Director of Dual Diagnosis Treatment Program, Harbor/UCLA Medical Center, Torrance, CA


American Board of Neurology and Psychiatry, 1993
ASAM Certified Addiction Specialist, Recertified 2015



  • 1997 – Selected as UCLA Department of Psychiatry and Behavioral Sciences Outstanding Medical Student Teacher of the Year
  • 1998 – Selected as an Outstanding Junior Investigators to present  at the APA Research Colloquium 5/98
  • 2002 – Winner of College on Problems of Drug Dependence and the Center for Substance Abuse Treatment Travel Award in Quebec, Canada, 2002
  • 2004 – Selected NAMI National’s 2004 Exemplary Psychiatrist Award for Exemplary Training Program, Award given at 2004 annual APA meeting
  • 2005 – NAMI’s Peggy and Don Richardson Memorial Award, 2005


Reviewer for Journal of Psychiatric Research, European Journal of Psychiatry, American Journal of Orthopsychiatry Journal, Schizophrenia Bulletin, Journal of American Medical Association, Reviewer for Journal of Clinical Psychiatry, Journal of Studies on Alcohol. Examiner, American Board of Psychiatry and     Neurology, Part II, oral exam



  • 1998-2000, Principal Investigator: “Treatment of Olanzapine with Haloperidol for Schizophrenic Patients with Substance Dependence”
  • 1999-2000, Principal Investigator:  “Single Blind Comparison of Clozapine versus Fluphenazine for Schizophrenic Patients with Substance Dependence”, VA Merit II grants
  • 2001-2006, Principal Investigator:  “MR Spectroscopic Analysis of Bipolar Disorder and Alcohol Abuse”, K23, MH01813-01a2
  • 2001-2004, Principal Investigator:  “A Pilot Study of MR spectroscopy in Bipolar Depressions”, Glaxo Smith-Kline funding
  • 2004-2009, Co-Investigator, “ Alcohol Pharmacogenetics in Mexican American”, NIAAA, Project #11996-01-00
  • 2005-2007, Co-Investigator (Harbor):  “Acupunture for the Treatment of Methamphetamine Withdrawal: Nitric Oxide Mechanisms”, Harbor/UCLA Seed Grant
  • 2011-2013, Principle Investigator: Phase I Safety interaction Trial of Ibudilast with Methamphetamine, NIDA grant
  • 2011-2014, Principle Investigator: Varenicline for methamphetamine dependence, NIDA grant.


More than 64 publications on topics related to substance abuse issues such as pharmacology and psychosocial treatment of dual diagnosis patients, treatment of alcoholism and methamphetamine addiction, and studies on opioid addictions.


Director, CME course at the American Psychiatric Association Annual Meeting for 16 years; multiple workshop  presentations for National Meetings for addiction related issues; panel member at APA National Meeting.


More than 300 Grand Round Presentation at academic centers nationally and internationally.